May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Michael Duruisseaux: Phase 3 DeLLphi-304 – Tarlatamab Meets OS Endpoint in SCLC
Apr 14, 2025, 04:39

Michael Duruisseaux: Phase 3 DeLLphi-304 – Tarlatamab Meets OS Endpoint in SCLC

Michael Duruisseaux, Medical Director of the Joint Research Unit in Thoracic Oncology of the Hospices Civilians of Lyons, shared a post on X:

“Phase 3 DeLLphi-304 is clinical trial evaluating Tarlatamab vs SOC chemo in SCLC who progressed after front-line platinum-based chemo met its primary endpoint of OS. Can’t wait to see the data.”

First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy, for Patients With Progression On or After Platinum-Based Chemotherapy